German Federal Court of Justice Reviews Advertising Limits for Medical Cannabis Platforms
2026-02-12 | According to a video report by Tagesschau, the Federal Court of Justice (BGH) is examining the extent to which online platforms may advertise medical treatments involving medical cannabis. The case stems from a legal dispute between the Centre for Protection Against Unfair Competition and the Frankfurt-based company Bloomwell, which connects patients with physicians. The plaintiff argues that the company’s online presence violates Germany’s pharmaceutical advertising law, which prohibits the promotion of prescription-only medicines to patients. The purpose of these restrictions is to prevent patients from exerting pressure on doctors to obtain specific medications.
Source German Cannabis Assoc Newsletter
